Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach

BMC Musculoskeletal Disorders

Volumn 9, Issue , 2008, Pages

  Dumitrescu, Bianca ^a,b   Van Helden, Svenjhalmar ^a   Ten Broeke, Rene ^a   Nieuwenhuijzen Kruseman, Arie ^a   Wyers, Caroline ^c   Udrea, Gabriela ^b   Linden, Sjef Van Der ^a   Geusens, Piet ^a,d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; CALCIUM;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL EVALUATION; FEMALE; FRACTURE; FRAGILITY FRACTURE; GROUPS BY AGE; HORMONE DEFICIENCY; HUMAN; INJURY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; VERTEBRA FRACTURE; VERTEBRA MALFORMATION; VITAMIN D DEFICIENCY; BLOOD; BONE DENSITY; CONNECTIVE TISSUE DISEASE; ENDOCRINE DISEASE; GASTROINTESTINAL DISEASE; HYPERPARATHYROIDISM; KIDNEY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BONE DENSITY; CALCIUM; CONNECTIVE TISSUE DISEASES; ENDOCRINE SYSTEM DISEASES; FEMALE; FRACTURES, BONE; GASTROINTESTINAL DISEASES; HUMANS; HYPERPARATHYROIDISM; KIDNEY DISEASES; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; THYROTROPIN; VITAMIN D DEFICIENCY;

EID: 51449116649     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-9-109     Document Type: Article

References (47)

1. Bone and fall-related fracture risks in women and men with a recent clinical fracture. S van Helden AC van Geel PP Geusens A Kessels AC Nieuwenhuijzen Kruseman PR Brink, J Bone Joint Surg Am 2008/02/05 2008 90 2 241 248 10.2106/JBJS.G.00150 18245581
2. Review and evaluation of the Dutch guidelines for osteoporosis. PP Geusens WF Lems HJ Verhaar G Leusink S Goemaere H Zmierczack J Compston, J Eval Clin Pract 2006 12 5 539 548 10.1111/j.1365-2753.2006.00647.x 16987116
3. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. C Tannenbaum J Clark K Schwartzman S Wallenstein R Lapinski D Meier M Luckey, J Clin Endocrinol Metab 2002 87 10 4431 4437 10.1210/jc.2002-020275 12364413
4. Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 2003 921 1 164, back cover 15293701
5. Secondary causes of osteoporosis. LA Fitzpatrick, Mayo Clin Proc 2002 77 5 453 468 12004995
6. Secondary contributors to bone loss in osteoporosis related hip fractures. BJ Edwards CB Langman AD Bunta M Vicuna M Favus, Osteoporos Int 2008/01/09 2008 18180974
7. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J 2001 94 6 569 573 11440324
8. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994 843 1 129 7941614
9. Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease. JA Kanis P Geusens C Christiansen, Osteoporos Int 1991 1 3 182 188 10.1007/BF01625451 1790407
10. Richtlijn Preventie van valincidenten bij ouderen. Utrecht, Kwaliteitsinstitut voor de Gezondheidszorg 2004
11. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. ES Siris HK Genant AJ Laster P Chen DA Misurski JH Krege, Osteoporos Int 2007 18 6 761 770 10.1007/s00198-006-0306-8 17245546
12. WHO Fracture Risk Assessment Tool. AJ Kanis, february, 2008 http://www.shef.ac.uk/FRAX/
13. PRIMER on the Metabolic Bone Diseases and Disorders of the Mineral Metabolism. DMJ Favus, Best Pract Res Clin Rheumatol American Society for Bone and Mineral Research 12 2006 1
14. Beyond bone mineral density-navigating the laboratory assessment of patients with osteoporosis. RB Wagman R Marcus, J Clin Endocrinol Metab 2002 87 10 4429 4430 10.1210/jc.2002-021310 12364412
15. Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. HA Deutschmann M Weger W Weger P Kotanko MJ Deutschmann F Skrabal, J Intern Med 2002 252 5 389 397 10.1046/j.1365-2796. 2002.01040.x 12528756
16. Characteristics of elderly patients admitted to an urban tertiary care hospital with osteoporotic fractures: correlations with risk factors, fracture type, gender and ethnicity. C Becker S Crow J Toman C Lipton DJ McMahon W Macaulay E Siris, Osteoporos Int 2006 17 3 410 416 10.1007/s00198-005-0001-1 16283067
17. The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 2006 13 6 862 77; quiz 878-80 10.1097/01.gme.0000243566.25205.0b 17106282
18. Review of guidelines for testing and treatment of osteoporosis. PP Geusens, Curr Osteoporos Rep 2003 1 2 59 65 10.1007/s11914-003-0010-y 16036066
19. Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. AA Ismail C Cooper D Felsenberg J Varlow JA Kanis AJ Silman TW O'Neill, Osteoporos Int 1999 9 3 206 213 10.1007/s001980050138 10450408
20. [Estimation of renal function in clinical routine: which is the best method?]. P Saile R Fiedler S Markau C Kuhn B Osten, Dtsch Med Wochenschr 2007 132 20 1093 1097 10.1055/s-2007-979384 17492567
21. Estimates of optimal vitamin D status. B Dawson-Hughes RP Heaney MF Holick P Lips PJ Meunier R Vieth, Osteoporos Int 2005 16 7 713 716 10.1007/s00198-005-1867-7 15776217
22. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. MF Holick ES Siris N Binkley MK Beard A Khan JT Katzer RA Petruschke E Chen AE de Papp, J Clin Endocrinol Metab 2005 90 6 3215 3224 10.1210/jc.2004-2364 15797954
23. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. RP Heaney KM Davies TC Chen MF Holick MJ Barger-Lux, Am J Clin Nutr 2003 77 1 204 210 12499343
24. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. E Nieschlag R Swerdloff HM Behre LJ Gooren JM Kaufman JJ Legros B Lunenfeld JE Morley C Schulman C Wang W Weidner FC Wu, Int J Androl 2005 28 3 125 127 10.1111/j.1365-2605.2005.00553.x 15910536
25. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview. GR Bailie SG Massry, Pharmacotherapy 2005 25 12 1687 1707 10.1592/phco.2005.25.12.1687 16305288
26. Lactose intolerance: problems in diagnosis and treatment. AD Shaw GJ Davies, J Clin Gastroenterol 1999 28 3 208 216 10.1097/00004836-199904000-00005 10192605
27. Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. EM Lewiecki AJ Laster, J Clin Endocrinol Metab 2006 91 11 4215 4222 10.1210/jc.2006-1178 16940447
28. Vertebral fractures in osteoporosis: a new method for clinical assessment. HK Genant J Li CY Wu JA Shepherd, J Clin Densitom 2000 3 3 281 290 10.1385/JCD:3:3:281 11090235
29. Vertebral fracture assessment using a semiquantitative technique. HK Genant CY Wu C van Kuijk MC Nevitt, J Bone Miner Res 1993 8 9 1137 1148 8237484
30. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. TE McAlindon DT Felson Y Zhang MT Hannan P Aliabadi B Weissman D Rush PW Wilson P Jacques, Ann Intern Med 1996 125 5 353 359 8702085
31. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. S Boonen HA Bischoff-Ferrari C Cooper P Lips O Ljunggren PJ Meunier JY Reginster, Calcified tissue international 2006 78 5 257 270 10.1007/s00223-005-0009-8 16622587
32. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. S Boonen D Vanderschueren P Haentjens P Lips, Journal of internal medicine 2006 259 6 539 552 10.1111/j.1365-2796.2006.01655.x 16704554
33. The role of vitamin D in fracture prevention. DH B, BoneKEy-Osteovision 2005 2 4 6 10 http://www.bonekey-ibms.org/content/vol2/issue4
34. The Vitamin D requirement in health and disease. RP Heaney, J Steroid Biochem Mol Biol 2005 97 1-2 13 19 10.1016/j.jsbmb.2005.06.020 16026981
35. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. MC Chapuy AM Schott P Garnero D Hans PD Delmas PJ Meunier, J Clin Endocrinol Metab 1996 81 3 1129 1133 10.1210/jc.81.3.1129 8772587
36. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. HA Bischoff HB Stahelin W Dick R Akos M Knecht C Salis M Nebiker R Theiler M Pfeifer B Begerow RA Lew M Conzelmann, J Bone Miner Res 2003 18 2 343 351 10.1359/jbmr.2003.18.2.343 12568412
37. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. DC Bauer B Ettinger MC Nevitt KL Stone, Ann Intern Med 2001 134 7 561 568 12803168
38. Hyperthyroidism, bone mineral, and fracture risk - a meta-analysis. P Vestergaard L Mosekilde, Thyroid 2003 13 6 585 593 10.1089/105072503322238854 12930603
39. Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. P Vestergaard L Rejnmark L Mosekilde, Calcif Tissue Int 2005 77 3 139 144 10.1007/s00223-005-0068-x 16151671
40. Idiopathic hypercalciuria. SE Liebman JG Taylor DA Bushinsky, Curr Rheumatol Rep 2006 8 1 70 75 10.1007/s11926-006-0029-z 16515769
41. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. E Nieschlag R Swerdloff HM Behre LJ Gooren JM Kaufman JJ Legros B Lunenfeld JE Morley C Schulman C Wang W Weidner FC Wu, J Androl 2006 27 2 135 137 10.2164/jandrol.05047 16474020
42. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. JT Chang SC Morton LZ Rubenstein WA Mojica M Maglione MJ Suttorp EA Roth PG Shekelle, Bmj 2004 328 7441 680 15031239 10.1136/bmj.328.7441.680
43. A multidisciplinary, multifactorial intervention program reduces postoperative falls and injuries after femoral neck fracture. M Stenvall B Olofsson M Lundstrom U Englund B Borssen O Svensson L Nyberg Y Gustafson, Osteoporos Int 2007 18 2 167 175 17061151 10.1007/s00198-006-0226-7
44. 2004 Surgeon General's Report on Bone Health and Osteoporosis: What It Means To You. US Department of Health and Human Services, 2004 http://www.surgeongeneral.gov/library/bonehealth/docs/Osteo10sep04.pdf
45. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. JA Kanis N Burlet C Cooper PD Delmas JY Reginster F Borgstrom R Rizzoli, Osteoporos Int 2008/02/13 2008 19 4 399 428 10.1007/s00198-008-0560-z 18266020
46. An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. T Chevalley P Hoffmeyer JP Bonjour R Rizzoli, Osteoporos Int 2002/07/11 2002 13 6 450 455 10.1007/s001980200053 12107657
47. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. AC Feldstein GA Nichols PJ Elmer DH Smith M Aickin M Herson, J Bone Joint Surg Am 2003/12/12 2003 85-A 12 2294 2302 14668497